Chidem Kurdas
Despite legal and market challenges, pharmaceutical and biotech stocks remain a wellspring of investment strategies. A popular play recently (more…)
Chidem Kurdas
Despite legal and market challenges, pharmaceutical and biotech stocks remain a wellspring of investment strategies. A popular play recently (more…)
Having sold an interest in Talecris Biotherapeutics to Grifols SA, a Spanish company with worldwide biopharmaceutical and other medical businesses, Cerberus Capital (more…)